Blood Pressure Drug Recall Affects Two New Products

Comments (0)

The U.S. Food and Drug Administration has issued a new recall which has been traced to the blood pressure medication valsartan. Similar valsartan products have been recalled last month. A large recall of drugs containing valsartan affected a number of companies and medications over the summer.

Valsartan and similar products were recalled because the drugs were linked to an impurity called NDEA, which was present in the drugs. NDEA has been classified as a “probable human carcinogen”. NDEA is used primarily as a stabilizer in gasoline and other fuels.

The two new products that were recalled are combination pills that are produced by Teva Pharmaceuticals. The recalled products include amlodipine/valsartan pills and amlodipine/valsartan/hydrochlorothiazide pills.

According to the FDA, patients who are currently in possession of these medications should continue taking them until they can get advice from a doctor or pharmacist about taking an alternative drug. The FDA says that the risk of harm to a patient’s health may be greater if the treatment is stopped immediately without any alternative treatment.

Many drug companies make hundreds of millions or even billions in profits. If a drug company produces a product which harms a consumer, the consumer can legally sue the drug company for compensation for their damages. The damages could include money for medical expenses, lost wages, pain and suffering, and more.

If you have been harmed by a defective drug, call the Houston defective prescription drug attorneys at Kennedy Hodges at 855-947-0707. We can help. Call us today to schedule a free consultation, or visit our YouTube channel to learn more.
Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.